SLTM Solta Medical, (MM)

First and only specialized clinic furthers AED industry-leading commitment to research and development HAYWARD, Calif., March 5 /PRNewswire-FirstCall/ -- Solta Medical, Inc. (NASDAQ:SLTM) today announced the opening of the Solta Medical Aesthetic Center to advance the company's new product development, facilitate research on the innovative Thermage(R) and Fraxel(R) product lines and serve as a destination where physicians can participate in research studies and training. Solta is the first company in the aesthetic energy device (AED) space with an in-house clinic and biomedical engineering lab. "The Solta Medical Aesthetic Center supports our pursuit of excellence in branded aesthetic treatments, enhances our ability to quickly bring new products to market and ensures the quality of anti-aging solutions we offer to patients and physicians," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "We invite physicians to visit our Aesthetic Center and see firsthand why Thermage and Fraxel systems are leading the way in terms of clinical outcomes, patient satisfaction and return on our customers' investment." Currently, there are more than 4,500 physicians in nearly 80 countries who perform Thermage and Fraxel treatments. The Aesthetic Center serves as a central research destination for physicians around the world to access the latest findings about Thermage and Fraxel treatments. "The Solta Medical Aesthetic Center allows for a seamless transition from the research bench to the treatment room," said Vic A. Narurkar, M.D., dermatologist and founder of the Bay Area Laser Institute in San Francisco, California. "Solta's state-of-the-art clinic allows the company's optics and biomedical engineers to share data and receive immediate clinical feedback about their work in new product development and existing product enhancement." Solta Medical has a history of leading the AED space in R&D, including the following noteworthy accomplishments: -- 200+ issued/pending patents -- 30 FDA 510(k) notification clearances -- 100 IRB approved clinical studies -- 18 IDE studies leading to new product development -- Over 1,500 IRB study treatments and 2,500 total procedures completed in the center -- 40,000 Histologies -- Approximately 100 peer-reviewed publications Current studies being conducted at the Aesthetic Center include the recently released Thermage Body Tip 16.0 and several advancements in skin tightening, resurfacing and other dermatological applications using new, breakthrough proprietary technology. The grand opening of the Solta Medical Aesthetic Center occurs in conjunction with the 67th annual meeting of the AAD in San Francisco. Several physicians presenting at the AAD will discuss their clinical findings using Thermage and Fraxel systems and the effectiveness of skin tightening and skin resurfacing. These presentations include: -- "Lasers, Non-Ablative Fractional Resurfacing," by Elizabeth Tanzi, M.D., Washington Institute of Dermatologic Surgery, Washington, D.C. on Friday, March 6, 2009 at 10:35 a.m. -- "Advanced Lasers, Fractional Resurfacing," by Christopher Zachary, F.R.C.P., University of California, Irvine, on Friday, March 6, 2009 at 3:15 p.m. -- "Skin Resurfacing & Rejuvenation, Carbon Dioxide Fractional Laser Rejuvenation," by Christopher Zachary, F.R.C.P., University of California, Irvine, on Saturday, March 7, 2009 at 11:10 a.m. -- "Fractional Laser and Light-based Technologies," by Vic A. Narurkar, M.D., founder of the Bay Area Laser Institute, San Francisco, CA, on Sunday, March 8, 2009 at 3:00 p.m. -- "Aesthetics and Cosmetic Surgical Procedures in Darker Racial Ethnic Groups, Fractional Photothermolysis & Radiofrequency Devices," by Vic Narurkar, M.D., founder of the Bay Area Laser Institute, San Francisco, CA, on Monday, March 9, 2009 at 11:01 a.m. ABOUT SOLTA MEDICAL Solta Medical is a global leader in the medical aesthetics market providing innovative, safe and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address aging skin under the industry's two premier brands: Thermage(R) and Fraxel(R). Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Since 2002, approximately one million Thermage and Fraxel procedures have been performed in nearly 80 countries. Thermage and Fraxel are the perfect complement for any aesthetic practice. For more information about Solta Medical, call 1-877-782-2286 or log on to http://www.solta.com/. DATASOURCE: Solta Medical, Inc. CONTACT: Company, Michael Hromadik of Solta Medical, Inc., +1-510-780-4694, ; or Media Relations, Chris Lalli of Cohn & Wolfe, +1-415-365-8540,

Copyright